Drug Reaction with Eosinophilia and Systemic Symptoms Secondary to Naproxen: A Case Report and Literature Review
暂无分享,去创建一个
[1] C. Sukasem,et al. Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population , 2017, Pharmacogenetics and genomics.
[2] A. Pannu,et al. Diagnostic criteria for drug rash and eosinophilia with systemic symptoms , 2017, Journal of family medicine and primary care.
[3] D. Naisbitt,et al. Drug‐specific CD4+ T‐cell immune responses are responsible for antituberculosis drug‐induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome , 2017, The British journal of dermatology.
[4] C. Strong,et al. Liver injury in patients with DRESS: A clinical study of 72 cases. , 2015, Journal of the American Academy of Dermatology.
[5] W. Chung,et al. Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS) , 2014, The British journal of dermatology.
[6] L. Naldi,et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study , 2013, The British journal of dermatology.
[7] R. Okuyama,et al. Clinical course of drug‐induced hypersensitivity syndrome treated without systemic corticosteroids , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.
[8] R. Schwartz,et al. DRESS syndrome: Part I. Clinical perspectives. , 2013, Journal of the American Academy of Dermatology.
[9] C. Chu,et al. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. , 2010, Archives of dermatology.
[10] M. Mockenhaupt,et al. Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? , 2007, The British journal of dermatology.
[11] T. Shiohara,et al. Several herpesviruses can reactivate in a severe drug‐induced multiorgan reaction in the same sequential order as in graft‐versus‐host disease , 2006, The British journal of dermatology.
[12] Yuan-Tsong Chen,et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] B. Thiers. HLA-B*5801 Allele as a Genetic Marker for Severe Cutaneous Adverse Reactions Caused by Allopurinol , 2006 .